Anthony R. Gregg, MD, MBA, FACMG President The Board of Directors of the College shall have the powers and duties ordinarily delegated to the governing body of a corporation, including: maintaining legal authority and responsibility; establishing general administrative procedures and transacting the general business of the College; adopting rules and regulations governing membership; reviewing and approval of all College statements and documents to be released to the public or to be submitted to a body outside of the College; establishing principles of professional conduct; and maintaining good relationships with other medical organizations, allied medical professionals, the public, and various constituencies. | ACMG Board of Directors |
Bruce R. Korf, MD, PhD, FACMG President The ACMG Foundation Board of Directors is the governing body of the ACMG Foundation and includes representatives from the American College of Medical Genetics, corporate representatives participating in the Partners in Science Program and directors representing the interests of the public. The ACMG Foundation is a charitable foundation of the American College of Medical Genetics. It is focused on funding educational activities related to medical genetics. | ACMG Foundation Board of Directors |
Bruce R. Korf, MD, PhD, FACMG Member The Foundation Development committee's purpose is to help identify and solicit new philanthropic sources of support. | ACMGF Development Committee |
Neel B. Shah, MD, FACMG Co-Chair The objectives and goals of the Adult Disease Special Interest Group are: (1)To foster awareness and understanding among stakeholders (consumers, health professionals, insurers, policy makers, etc.) of the role of clinical genetics and genomics in adult medicine (2) To support and provide evaluation of educational programs that address clinical genetics issues for adults; (3)To promote the use of and support the development of guidelines for the recognition, detection and management of adult genetic disorders (4)To promote research evaluating the clinical utility and outcomes of genetic intervention (evaluation/consultation) in the detection and management of adult genetic disorders and disease. | Adult Genetics Special Interest Group Executive Committee |
Sheila M. Dobin, PhD, FACMG Chair The Advocacy and Government Affairs Committee shall explore and report on public policies developed by government entities, such as the U.S. Congress, State Legislatures, and Federal Agencies, that impact the application of genetics and genomics in health care. The Committee will work closely with public policy staff to develop positions and advise on government affairs advocacy activities. When appropriate, the committee shall study, evaluate, and prepare information for dissemination to members of the College or to the public, subject to approval by the Board of Directors. When appropriate, the Committee will identify a liaison to other committees or workgroups of the College developing documents that may impact public policy (e.g., Economics, SELI, Lab QA). | Advocacy & Government Affairs |
Lisa A. Schimmenti, MD, FACMG Chair In 2003 the ABMS (American Board of Medical Specialties) began to develop an expanded four part Maintenance of Certification plan that each member Board would be required to have in place by 2009. This four part MOC plan is uniform across Boards in concept, but can vary somewhat in the specifics. The long term plan for the Continuing Certification Program (CCP formerly MOC) committee is to provide ongoing guidance to the ABMGG and the ACMG in their efforts to develop the practical application of these plans. The vision for this joint committee is to use the experience and perspective of each committee member on questions of timing, scope of activities, as well as to guide the development practice improvement modules. | Continuing Certification Program Committee |
Jone E. Sampson, MD, FACMG Chair The Committee on the Economics of Genetic Services shall study and assess billing and reimbursement mechanisms for medical genetics services with the goals of (1) ensuring appropriate integration of genetics services into evolving national, state, and private health care schemes; (2) educating medical geneticists regarding appropriate procedures to be followed; and (3) maintaining and improving patient access to medical genetics services. | Economics of Genetic Services Committee |
Anne M. Slavotinek, MBBS, PhD, FACMG Chair The Education and CME Committee shall (1) study and evaluate various aspects of medical genetics education; (2) review and recommend proposed changes in medical genetics education; (3) consider and recommend means by which the College may provide information, direction, and leadership in the field of medical genetics education; (4) consider and recommend policies and procedures by which clinical and laboratory geneticists may be assisted in maintaining their professional competence, including continuing medical genetics education, and develop criteria whereby such achievement may be recognized; and (5) plan, organize, and conduct various educational activities of the College. | Education and CME Committee |
Catherine W. Rehder, PhD, FACMG Chair The Finance Committee is composed of the Treasurer of the College, appointed ACMG directors and at least two College members appointed by the ACMG President. The committee meets annually to review the prior year's financial statements and to plan a new budget for the upcoming year. The committee also studies, evaluates, and makes recommendations to the Board of Directors regarding the College's financial status. All recommendations of the Finance Committee require Board of Directors approval. | Finance Committee |
Fady M. Mikhail, MD, PhD, FACMG Chair The Laboratory Quality Assurance Committee shall be composed of the Vice President for Laboratory Genetics and such other members as shall be appointed by the President based upon the recommendation of the chairperson of the committee. The committee shall investigate and report to the Board of Directors on issues which arise from or may impact upon the provision of laboratory genetics services. Such issues may include scientific and technological advances, patient and clinician needs, laboratory accreditation, socioeconomic factors, and liability concerns. When appropriate, the committee shall study, evaluate, and prepare information for dissemination to members of the College or to the public, subject to approval by the Board of Directors. The CAP/ACMG liaisions report to this committee. | Laboratory Quality Assurance Committee |
Laurie A. Demmer, MD, FACMG Board Liaison The Membership Committee shall be composed of the Vice President for Clinical Genetics, the Vice President for Laboratory Genetics, the Secretary, and such other members as shall be appointed by the President based upon the recommendation of the chairperson of the committee. The committee shall (1) review applications for membership in the College and recommend qualified applicants to the Board of Directors for election to membership; (2) annually review the membership of the College to determine whether action is needed to maintain a proportional Fellowship and recommend such action, when necessary, to the Board of Directors; (3) periodically reassess membership classes and qualifications and report their findings to the Board of Directors; (4) develop programs for the promotion and retention of membership in the College; and (5) consider applicants' petitions for exceptions to membership qualifications and recommend appropriate exceptions, if any, to the Board of Directors. | Membership Committee |
Douglas R. Stewart, MD, FACMG Chair The Professional Practice and Guidelines Committee shall be composed of the Vice President for Clinical Genetics, the Vice President for Laboratory Genetics, and such other members as shall be appointed by the President based upon the recommendations of the chairperson of the committee. The committee shall create and maintain a system for developing statements and shall develop statements for the practice of medical genetics. This will include ensuring a system for the identification, format, development, dissemination, monitoring and review of statements. | Professional Practice and Guidelines Committee |
Anthony R. Gregg, MD, MBA, FACMG Board Liaison The Program Committee shall be composed of the chairperson of the Education Committee and such other members as shall be appointed by the President based upon the recommendation of the chairperson of the committee. The committee shall plan, implement, and conduct the annual meeting of the members of the College, evaluate potential sites for future annual meetings, and, as may be necessary, evaluate products or services submitted for exhibition at the annual meeting. | Program Committee for Annual Meeting |
Lynn W. Bush, PhD, MS Chair The mission of the Public Health Interest Group is to provide a forum for 1). Information sharing regarding programs in public health genetics and newborn screening; ethical, legal, and social issues in public health genetics and newborn screening; translational genetics activities; and scientific and clinical advances in public health genetics and newborn screening; 2). Development of policies and papers related to public health genetics and newborn screening to be shared, as appropriate, with ACMG committees and/or Board of Directors. | Public Health Genetics SIG Executive Committee |
Edina Torgyekes, MD, FACMG Chair Quality improvement (QI) in clinical medicine is increasingly recognized as a robust approach to rapidly correct problems and improve the care of patients. QI is an iterative process that continues to modify the system to continuously improve outcomes, and insure that the improved outcome persists. QI projects of the ACMG SIG include: Metabolic Disease data collection and follow-up; Family History; Evaluation of Developmental Delay and Mental Retardation; Neurofibromatosis Type 1; Evidence-based interventions for Autism; Genetics Pedigree Project; Patient Satisfaction Survey Standardization. | Quality Improvement Special Interest Group |
Karen W. Gripp, MD, FACMG Board Liaison The Social, Ethical, and Legal Issues Committee shall be composed of such members as shall be appointed by the President based upon the recommendation of the chairperson of the committee. The committee shall consider and report to the Board of Directors on social and ethical issues which arise from or may impact upon the delivery of clinical genetics or laboratory genetics services. Such issues may include access to medical genetics services, informed consent, confidentiality, disclosure of genetic information to third parties, and discrimination based on genetic status. When appropriate, the committee shall study, evaluate, and prepare information for dissemination to members of the College or to the public, subject to approval by the Board of Directors. | Social, Ethical and Legal Issues Committee |
Lynn D. Fleisher, PhD, JD, FACMG Board Liaison The Social, Ethical, and Legal Issues Committee shall be composed of such members as shall be appointed by the President based upon the recommendation of the chairperson of the committee. The committee shall consider and report to the Board of Directors on social and ethical issues which arise from or may impact upon the delivery of clinical genetics or laboratory genetics services. Such issues may include access to medical genetics services, informed consent, confidentiality, disclosure of genetic information to third parties, and discrimination based on genetic status. When appropriate, the committee shall study, evaluate, and prepare information for dissemination to members of the College or to the public, subject to approval by the Board of Directors. | Social, Ethical and Legal Issues Committee |
Kim L. McBride, MD, MS, FACMG Chair The Therapeutics Committee was established to deal with the unique issues which physicians and their patients face with therapies for genetic disorders. The committee covers these issues by forming working groups; holding workshops at the ACMG annual meetings; writing position papers; participating in national meetings on therapeutic issues; and collaborating with other ACMG committees, SIMD and other professional groups, NORD and other patient groups, and NIH ORD, the FDA, OHRP, and other government agencies. | Therapeutics Committee |
Laurie A. Demmer, MD, FACMG Chair Topic Selection Committee | Topic Selection Committee |